Invictus MD is a public company trading on the TSXv (GENE) and OTC (IVITF). The company is focused on acquiring Licensed Producers in Canada under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") and has recently acquired an interest in a ACMPR license held by AB Laboratories based out of Hamilton, Ontario.
